Artículos del autor

solaci

Institutional News

MIL Train More MIL – The Second Week of Training Is Starting!

The second week of our structural heart disease training program for Latin American interventionists women is being...
solaci -
Chronic Coronary Syndromes

ISCHEMIA Trial: Does Complete Anatomical or Functional Revascularization Modify Anything Compared with Medical Treatment?

Chronic coronary syndrome (CCS) has been considered another comorbidity in previous studies, and there has been no...
solaci -
Institutional News

Watch Again Are You Ready for Left Main?

You can now relive our virtual event on Are You Ready for Left Main? on our YouTube...
solaci -
Acute coronary syndromes

Substudy TALOS AMI: from Ticagrelor to Clopidogrel in Patients with High Risk of Bleeding and AMI

The preference for the use of potent P2Y12 inhibitors such as ticagrelor and prasugrel in patients with...
solaci -
Acute coronary syndromes

AMI and Multivessel Disease: Can We Perform a Single Procedure?

Percutaneous coronary intervention (PCI) is considered the treatment of choice in ST-segment elevation myocardial infarction (STEMI). However,...
solaci -
Mitral valve

TRILUMINATE Two Years In: Encouraging Results

Tricuspid valve regurgitation is more common than one might think. It often stems from left valve disease...
solaci -
Bifurcations

BIFURCAT Registry: Long Term Diabetes Impact on Bifurcations PCI Outcomes

The impact of diabetes in patients with coronary artery disease (CAD) are well known, and after percutaneous...
solaci -
Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy: Long Term Survival with Alcohol Septal Ablation according to Hemodynamic Variables

Left ventricular outflow tract (LVOT) obstruction is an integral component of hypertrophic cardiomyopathy (HCM). Both chemical myomectomy...
solaci -